NFHHMUi001-A

General

Cell Line

hPSCreg name NFHHMUi001-A
Cite as:
NFHHMUi001-A (RRID:CVCL_C1V1)
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
HEBHMUi008-A
Donor's gene variants:
APOE
Donor diseases:
cerebrovascular disease
USFi001-A
(1CN1.5)
Donor diseases:
Friedreich Ataxia
LZUSHi001-A
(ips98)
Donor diseases:
Generalized Epilepsy
NIHTVBi022-A
(HT964)
Donor diseases:
Leukodystrophy
FJMUUHi001-A
Donor's gene variants:
PARK7
Donor diseases:
Parkinson's disease 7
SIAISi007-A
(ZSJ)
Donor diseases:
Alzheimer's Disease
PNUSCRi001-A
(GBA PD iPSC7)
Donor's gene variants:
GBA
Donor diseases:
Parkinson Disease
PNUSCRi002-A
(GBA PD iPSC9)
Donor's gene variants:
GBA
Donor diseases:
Parkinson Disease
ICGi042-A
(PD12-4Lm)
Donor's gene variants:
LRRK2, PINK1
Donor diseases:
Parkinson Disease
MUNIi013-A
(BAD4, sAD3)
Donor diseases:
Alzheimer's Disease
ICGi042-B
(PD12-5Lm)
Donor's gene variants:
LRRK2, PINK1
Donor diseases:
Parkinson Disease
ICGi042-C
(PD12-6Lm)
Donor's gene variants:
LRRK2, PINK1
Donor diseases:
Parkinson Disease
JUCGRMi001-A
(VPS35A4)
Donor diseases:
Parkinson Disease
JUCGRMi001-B
(VPS35A5)
Donor diseases:
Parkinson Disease
JUCGRMi001-C
(VPS35A8)
Donor diseases:
Parkinson Disease
UKBi011-A
(iLB-AD-169bm-s24)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
IPTi003-A
(15M0010)
Donor diseases:
obsolete_Alzheimer's disease
IPTi004-A
(15M0011)
Donor diseases:
obsolete_Alzheimer's disease
ICGi023-A
(PD45-6-1Lm)
Donor's gene variants:
LRRK2
Donor diseases:
Parkinson Disease
PFIZi029-A
(B222c4)
Donor's gene variants:
CHD2
Donor diseases:
myoclonic epilepsy
PUFHi004-A
(TMEM163 c.227T>C p.(Leu76Pro) iPSC)
Donor's gene variants:
TMEM 163
Donor diseases:
Leukodystrophy
SHCDNi006-A
(SHCDN006)
Donor diseases:
epilepsy
ZJSHi001-A
(ZJSHi-KCNB1)
Donor's gene variants:
KCNB1
Donor diseases:
developmental and epileptic encephalopathy, 26
PFIZi023-A
(B217c8)
Donor's gene variants:
GPR56, GPR56
Donor diseases:
Bilateral Frontoparietal Polymicrogyria
NIHTVBi019-A
(HT852)
Donor diseases:
Leukodystrophy
PFIZi025-A
(B220c16)
Donor's gene variants:
KCNC1
Donor diseases:
epilepsy
CMGANTi005-A
(iPSC_MFS_FBN1_MCE-KB_C8)
Donor diseases:
Marfan Syndrome
Last update 16th June 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Department of Neurosurgery of The First Affiliated Hospital of Harbin Medical University (NFHHMU)

External Databases

BioSamples SAMEA13602499
Cellosaurus CVCL_C1V1
Wikidata Q114312505

General Information

Publications
* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex male
Ethnicity Han

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Synonyms
  • Cerebral Cavernous Malformation

Karyotyping (Donor)

Has the donor karyotype been analysed?
No

External Databases (Donor)

BioSamples SAMEA14251112

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? 哈尔滨医科大学附属第一医院临床研究管理委员会(Clinical Research Management Committee of the First Affiliated Hospital of Harbin Medical University)
Approval number 2020IIT038
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A sample of peripheral blood mononuclear cells.
Synonyms
  • Peripheral Blood Mononuclear Cell Specimen
  • PBMC Specimen
  • PBMC Sample
  • Peripheral Blood Mononuclear Cell Sample
  • Peripheral Blood Mononuclear Cell (PBMC)
show more synonyms

Reprogramming method

Vector type Non-integrating
Vector Episomal
Genes
Is reprogramming vector detectable?
No
Methods used
PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Yes
Available as clinical grade?
Unknown

Culture Conditions

Medium Other medium:
Base medium: Nuwacell ncTarget hPSC Medium
Main protein source:
Serum concentration: %

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SSEA-4
Yes
TRA 1-81
Yes
Score:
Marker Present Absent
mCpG
OCT4
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vivo teratoma
Mesoderm
Ont Id: UBERON_0000926
In vivo teratoma
Ectoderm
Ont Id: UBERON_0000924
In vivo teratoma

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XY
Karyotyping method: G-Banding

Other Genotyping (Cell Line)